Interestingly, the AML FLT3‐ITD subtype was shown to overexpress miR‐155, an oncogene known to accelerate AML progression (Gerloff et al, 2015; Salemi et al, 2015). This evidence concerns the gene FLT3 and acute myeloid leukemia.